Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Comparison of Adenosine Deaminase Level in Serum and Synovial Fluid in Patients With Juvenile Idiopathic Arthritis and Its Relation to Inflammatory Acute Phase Reactants Publisher



Rahmani K1, 2 ; Raeeskarami SR3, 4 ; Ziaee V3, 4, 5 ; Sadeghi P4 ; Moradinejad MH1, 4, 5 ; Haghiashtiani MT1, 6
Authors

Source: Iranian Journal of Pediatrics Published:2017


Abstract

Background: In JIA, cell-mediated immune response results in secretion of different inflammatory products from activated lym-phocytes, macrophages, fibroblasts and leukocytes in synovial joints. Adenosine deaminase (ADA) regulates this immune system activity by metabolizing adenosine through purine metabolic pathway. Objectives: The aim of this study was to compare the level of serum ADA with synovial fluid ADA in JIA patients and to see whether it can be utilized as a marker for the activity of the disease Methods: JIA was diagnosed based on International League of Associations for Rheumatology diagnosis criteria. ADA was measured using special kits. Results: 80% of the patients had oligoarticular and 20% polarticulare JIA. There was a significant relation between erythrocyte sedimentation rate (ESR) and high level of synovial fluid ADA. Synovial ADA level was significantly higher than serum ADA in polyarticular JIA. C-reactive protein (CRP), leukocytes and platelets count were increased in high levels of synovial fluid ADA. No correlation was observed between level of serum and synovial fluid ADA. Conclusions: Synovial fluid ADA seems a more precise index than serum ADA to assess the inflammatory condition. In addition, acute-phase response reactants such as ESR, CRP, and platelets count could be suitable predicting parameters for arthritis. © 2017, Iranian Journal of Pediatrics.
Other Related Docs
4. Epidemiology of Rheumatic Diseases in Iran From Analysis of Four Copcord Studies, International Journal of Rheumatic Diseases (2016)
16. Translational Autoimmunity: Volume 6: Advances in Autoimmune Rheumatic Diseases, Translational Autoimmunity: Volume 6: Advances in Autoimmune Rheumatic Diseases (2023)